|
|
|
|
Molecular Pharmacology, Vol 7, 663-673, Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Experimental Therapeutics, Roswell Park Memorial Institute, New York State
Department of Health, Buffalo, New York 14203
Adenosine kinase (ATP:adenosine 5'-phosphotransferase, EC 2.7.1.20) was partially purified by DEAE-cellulose column chromatography from Sarcoma 180 cells grown in vitro. This enzyme preparation, which was free of adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) but contained adenylate kinase (ATP:AMP phosphotransferase, EC 2.7.4.3), was studied with respect to its kinetic properties and specificity for substrates and inhibitors.
At pH 7.0 and 35° the Km for adenosine was 0.5 µM and the Vmax was 63 mµmoles/mg of protein per minute. Strong substrate inhibition was observed at adenosine concentrations greater than 4 µM, 50% inhibition occurring at about 100 µM. The reaction required ATP (Km = 200 µM) and Mg++. The optimal Mg++ concentrations were 0.1 and 0.25 mM at 0.5 and 2.5 mM ATP, respectively. Concentrations of Mg++ higher than these were inhibitory, and Mn++ substituted poorly for Mg++.
Most of the N6-substituted adenosine analogues which were substrates of adenosine kinase
inhibited the growth of S-180 cells in vitro. Among these were two compounds which are also
known to be potent cytokinins in plant systems, namely, N6-furfuryl- and N6-(
2-isopentenyl)adenosine. The 5'-monophosphate of the latter compound was not phosphorylated
further by adenylate kinase. The N6-substituted adenosines which were poorly or not at all
phosphorylated by adenosine kinase were also poor inhibitors of S-180 cells in vitro. Several
of these were potent inhibitors of the kinase, such as N6-phenyladenosine, which had a Ki
value of 0.6 µM.
Note:
ACKNOWLEDGMENT
The authors wish to express their appreciation
to Miss Dorris Sugg for her excellent assistance
in these studies.